Long-term outcome of non-ablative booster BMT in patients with SCID

Bone Marrow Transplantation

Volumn 48, Issue 8, 2013, Pages 1050-1055

  Teigland, C L ^a   Parrott, R E ^a   Buckley, R H ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

2 parent BM transplants; Booster; SCID

Indexed keywords

ARTICLE; BONE MARROW TRANSPLANTATION; CELLULAR IMMUNITY; CHILD; CLINICAL ARTICLE; FEMALE; FLOW CYTOMETRY; GRAFT VERSUS HOST REACTION; GRAM NEGATIVE SEPSIS; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; INFANT; LIFE EXPECTANCY; LUNG DISEASE; LYMPHOCYTE FUNCTION; MALE; MYCOSIS; NEUROLOGIC DISEASE; NEWBORN; NON ABLATIVE BOOSTER BONE MARROW TRANSPLANTATION; OUTCOME ASSESSMENT; PARENT; PNEUMOCYSTIS PNEUMONIA; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; SEVERE COMBINED IMMUNODEFICIENCY; SURVIVAL RATE; SURVIVAL TIME; T CELL DEPLETION; THRUSH; VIRUS INFECTION;

BONE MARROW TRANSPLANTATION; FEMALE; GRAFT VS HOST DISEASE; HUMANS; INFANT; INFANT, NEWBORN; MALE; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; SEVERE COMBINED IMMUNODEFICIENCY; T-LYMPHOCYTES; TRANSPLANTATION CHIMERA; TREATMENT OUTCOME;

EID: 84881371331     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2013.6     Document Type: Article

References (29)

1. Buckley RH. Molecular defects in human severe combined immunodeficiency and approaches to immune reconstitution. Annu Rev Immunol 2004; 22: 625-655
2. Buckley RH. Transplantation of hematopoietic stem cells in human severe combined immunodeficiency: Longterm outcomes. Immunol Res 2011; 49: 25-43
3. Buckley RH, Schiff SE, Schiff RI, Markert L, Williams LW, Roberts JL et al. Hematopoietic stem cell transplantation for the treatment of severe combined immunodeficiency. N Engl J Med 1999; 340: 508-516
4. Myers LA, Patel DD, Puck JM, Buckley RH. Hematopoietic stem cell transplantation for severe combined immunodeficiency in the neonatal period leads to superior thymic output and improved survival. Blood 2002; 99: 872-878
5. Kline RM, Stiehm ER, Cowan MJ. Bone marrow 'boosts' following T cell depleted haploidentical bone marrow transplantation. Bone Marrow Transplant 1996; 17: 543-548
6. Remberger M, Ringden O, Ljungman P, Hagglund H, Winiarski J, Lonnqvist B et al. Booster marrow or blood cells for graft failure after allogeneic bone marrow transplantation. Bone Marrow Transplant 1998; 22: 73-78
7. Min CK, Kim DW, Lee JW, Min WS, Kim CC. Additional stem cell therapy for graft failure after allogeneic bone marrow transplantation. Acta Haematol 2000; 104: 185-192
8. Wolff SN. Second hematopoietic stem cell transplantation for the treatment of graft failure, graft rejection or relapse after allogeneic transplantation. Bone Marrow Transplant 2002; 29: 545-552
9. Slatter MA, Bhattacharya A, Abinun M, Flood TJ, Cant AJ, Gennery AR. Outcome of boost haemopoietic stem cell transplant for decreased donor chimerism or graft dysfunction in primary immunodeficiency. Bone Marrow Transplant 2005; 35: 683-689
10. Booth C, Ribeil JA, Audat F, Dal Cortivo L, Veys PA, Thrasher AJ et al. CD34 stem cell top-ups without conditioning after initial haematopoietic stem cell transplantation for correction of incomplete haematopoietic and immunological recovery in severe congenital immunodeficiencies. Br J Haematol 2006; 135: 533-537
11. Al-Herz W, Bousfiha A, Casanova J-L, Chapel H, Conley ME, Cunningham-Rundles C et al. Primary immunodeficiency diseases: An update on the classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency. Frontiers in Immunology 2011; 2: 54
12. Chinen J, Davis J, De Ravin SS, Hay BN, Hsu AP, Linton GF et al. Gene therapy improves immune function in preadolescents with X-linked severe combined immunodeficiency. Blood 2007; 110: 67-73
13. Buckley RH, Dees SC, O'Fallon WM. Serum immunoglobulins I. levels in normal children and in uncomplicated childhood allergy. Pediatr 1968; 41: 600-611
14. Buckley RH, Dees SC. Serum immunoglobulins. III. Abnormalities associated with chronic urticaria in children. J. Allergy 1967; 40: 294-303
15. Buckley RH, Schiff SE, Sampson HA, Schiff RI, Markert ML, Knutsen AP et al. Development of immunity in human severe primary T cell deficiency following haploidentical bone marrow stem cell transplantation. J Immunol 1986; 136: 2398-2407
16. Reisner Y, Kapoor N, Kirkpatrick D, Pollack MS, Cunningham-Rundles S, Dupont B et al. Transplantation for severe combined immunodeficiency with HLA-A, B, D, DR incompatible parental marrow cells fractionated by soybean agglutinin and sheep red blood cells. Blood 1983; 61: 341-348
17. Schiff SE, Kurtzberg J, Buckley RH. Studies of human bone marrow treated with soybean lectin and sheep erythrocytes: Stepwise analysis of cell morphology, phenotype and function. Clin Exp Immunol 1987; 68: 685-693
18. Railey MD, LoKhnygina Y, Buckley RH. Long term clinical outcome of patients with severe combined immunodeficiency who received related donor bone marrow transplants without pre-Transplant chemotherapy or post-Transplant GVHD prophylaxis. J Pediatr 2009; 155: 834-840
19. Haddad E, Deist FL, Aucouturier P, Cavazzana-Calvo M, Blanche S, Basile GD et al. Long-Term chimerism and B-cell function after bone marrow transplantation in patients with severe combined immunodeficiency with B cells: A single-center study of 22 patients. Blood 1999; 94: 2923-2930
20. Buckley RH. B-cell function in severe combined immunodeficiency after stem cell or gene therapy: A review. J Allergy Clin Immunol 2010; 125: 790-797
21. Buckley RH, Win CM, Moser BK, Parrott RE, Sajaroff E, Sarzotti-Kelsoe M. Posttransplantation B cell function in different molecular types of SCID. J Clin Immunol 2013; 33: 96-110
22. Palmer K, Green TD, Roberts JL, Sajaroff E, Cooney M, Parrott R et al. Unusual clinical and immunologic manifestations of transplacentally acquired maternal T cells in severe combined immunodeficiency. J Allergy Clin Immunol 2007; 120: 423-428
23. Koppelmans V, Breteler MM, Boogerd W, Seynaeve C, Gundy C, Schagen SB. Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy. J Clin Oncol 2012; 30: 1080-1086
24. Titman P, Pink E, Skucek E, O'Hanlon K, Cole TJ, Gaspar J et al. Cognitive and behavioural abnormalities in children following haematopoietic stem cell transplantation for severe congenital immunodeficiencies. Blood 2008; 112: 3907-3913
25. Sanders JE. the Seattle Marrow Transplant Group. Effects of bone marrow transplantation on reproductive function. Late Effects of Treatment for Childhood Cancer. Wiley-Liss Publishing Ltd: New York, NY, 1992, pp 95-101
26. Buckley RH. The long quest for neonatal screening for severe combined immunodeficiency. J Allergy Clin Immunol 2012; 129: 597-604
27. Hassan A, Booth C, Brightwell A, Allwood Z, Veys P, Rao K et al. Outcome of hematopoietic stem cell transplantation for adenosine deaminase-deficient severe combined immunodeficiency. Blood 2012; 120: 3615-3624
28. Aiuti A, Cattaneo F, Galimberti S, Benninghoff U, Cassani B, Callegaro L et al. Gene therapy for immunodeficiency due to adenosine deaminase deficiency. N Engl J Med 2009; 360: 447-458
29. Sideri A, Neokleous N, De La Grange PB, Guerton B, Le Bousse Kerdilles MC, Uzan G et al. An overview of the progress on double umbilical cord blood transplantation. Haematologica 2011; 96: 1213-1220